Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-17 · accession 0000914475-24-000138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-21 | 2024-05-17 | NBIX | Sharp Shalini | Dir | S - Sale+OE | $141.90 | -1,106 | 994 | -53% | -$156.9K |
| D | 2024-05-21 | 2024-05-17 | NBIX | Sharp Shalini | Dir | M - OptEx | $0.00 | +2,100 | 2,100 | New | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | Sharp Shalini | Dir | M - OptEx | $0.00 | -2,100 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-17 | S | D | 1,106 | $141.90 | 994 | D | — | — | (F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.81 to $142.33. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range |
| 2 | Common | Common Stock | 2024-05-17 | M | A | 2,100 | $0.00 | 2,100 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-05-17 | M | D | 2,100 | $0.00 | 0 | D | — · — to — | 2,100 Common Stock | (F3) Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock. (F4) This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested. |